# Cellid, Co., Ltd. (299660.KQ): MoatMap facts

As of 20 Oct 2026. Research data, not investment advice.

As of 20 Oct 2026, MoatMap's StockRank for Cellid, Co., Ltd. (299660.KQ) is 16/100, ranked against 24,000+ stocks in 35 markets (Quality 23, Value 33, Momentum 39, each scored against its sector).

- StockRank: 16/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 23, Value 33, Momentum 39: each a 0-100 percentile within the stock's sector.
- Position: #22,614 overall, #2,058 in Healthcare.
- Listing: South Korea, KOE; Healthcare / Biotechnology.
- Last close: 2,365 KRW on 19 Oct 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.

Source: https://moatmap.ai/stock/299660.KQ
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker